Iroquois Capital Management, LLC 13D and 13G filings for Petros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-23 4:25 pm Purchase | 2021-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Iroquois Capital Management, LLC | 4,777 4.990% | 1,880 (+64.88%) | Filing |
| 2021-10-22 06:51 am Purchase | 2021-10-18 | 13G | Petros Pharmaceuticals, Inc. PTPI | Iroquois Capital Management, LLC | 2,897 9.990% | 2,897 (New Position) | Filing |